Valbiotis
Pascal Sirvent serves as Chief Scientific Officer and Director of Discovery, Preclinical and Translational Research at Valbiotis since September 2017, focusing on executive management and research strategies in the field. Previously, Pascal held the position of Associate Professor at Université Clermont Auvergne from 2008 to 2018, coordinating preclinical and clinical studies on metabolic diseases and fostering international scientific partnerships. Early roles included scientist at Laboratoire LESCUYER, engineer at CHU de Montpellier, assistant professor at Inra, and lecturer at Université de Montpellier, with foundations laid as a PhD student at Inserm. Educational qualifications include a Habilitation à diriger des recherches from Université Clermont Auvergne and a PhD in Biological and Biochemical Sciences for Health from the University of Montpellier.
This person is not in any offices
Valbiotis
Valbiotis is a French Research & Development company committed to the prevention and fight against metabolic diseases.